Educational Webinars & Recordings

According to the American Cancer Society, there will be an estimated 114,810 new cases diagnosed and approximately 34,020 deaths from gynecologic cancers in the U.S. in 2023. Whether you or someone you love has been diagnosed with cancer, we’re here to help. The Foundation for Women’s Cancer (FWC) offers comprehensive information by cancer type to help guide you.

Below, you will find a listing of recent educational webinars. If you’d like to see the Foundation for Women’s Cancer full suite of course offerings, including the recently released series called “Compassionate Caregivers: Navigating Cancer’s Challenges,” please click here.

Chemotherapy Shortage: What Patients, Advocates & Survivors Need To Know

In this free webinar, FWC and SGO leaders share insightful information about the current chemotherapy drug shortages, including why the shortages are happening, what SGO and FWC are doing to address this issue, and what survivors and advocates can do to help make a change.

SGO 2023 Annual Meeting Scientific Debrief

This webinar highlights important research from the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer and how that research will impact patients. Hosted by Dr. Shannon Armbruster, with speaker from the Patient Education Committee, the webinar will cover new research in Ovarian Cancer, Endometrial Cancer, Cervical Cancer, and more followed by a question-and-answer session for each section.

Shared Decision Making in Ovarian Cancer

This webinar, featuring patient advocate Shirley Dau and gynecologic oncologist Dr. Nita Lee, focuses on the use of the “shared decision-making” model when seeking treatment for ovarian cancer. With a multitude of treatment modalities available, learn how to become your own advocate to obtain the most effective method possible in the treatment of your disease. This webinar is made possible through generous sponsorship support from AstraZeneca.

Survivors Exercise Together: The Benefits of Movement During COVID-19

This 30-minute webinar covered the benefits of movement in the survivor journey and ways to be active at home in the midst of the COVID-19 pandemic. Presenters discussed the physical and mental benefits of exercise, the benefits of yoga for cancer survivors and led a 5-minute gentle movement session.

What the COVID-19 Crisis Means for Gynecologic Cancer Patients

The coronavirus pandemic has added an extra layer of uncertainty to the lives of cancer patients. Join Dr. Stephanie V. Blank, Director of Gynecologic Oncology for the Mount Sinai Health System, and Dr. Melissa Frey, a gynecologic oncologist at Weill Cornell Medicine for updates on what ovarian, endometrial, and other gynecologic cancer patients need to know about managing gynecologic cancer concerns in the era of COVID-19. Bring your questions for the Q&A. This webinar is a collaboration between SHARE and the Foundation for Women’s Cancer.

Uterine and Endometrial Cancer 101

Gain a deeper understanding of uterine and endometrial cancer symptoms, diagnosis, treatment options and current research trends with Jason D. Wright, MD, Division Chief of Gynecologic Oncology at New York-Presbyterian/Columbia University Medical Center. This webinar is a collaboration between SHARE and the Foundation for Women’s Cancer.

2022 SGO Annual Meeting Scientific Debrief

Streamed on May 21, 2022
This on-demand video of our past webinar highlights important research from the Society of Gynecologic Oncology 2022 Annual Meeting on Women’s Cancer, and how that research will impact patients. Panelists explained new research in Ovarian Cancer, Endometrial Cancer, Cervical Cancer, and more followed by a question and answer session.

2021 Annual Meeting Scientific Debrief: What Patients Should Know

Streamed on July 10, 2021
This on-demand video of our past webinar highlights important research from the Society of Gynecologic Oncology 2021 Annual Meeting on Women’s Cancer, and how that research will impact patients. Panelists explained new research in Ovarian Cancer/PARP Inhibitors, Endometrial Cancer, Cervical Cancer and Survivorship, which was followed by a question and answer session.